A western blot assay to measure cyclin dependent kinase activity in cells or in vitro without the use of radioisotopes.
FEBS Lett
; 587(18): 3089-95, 2013 Sep 17.
Article
en En
| MEDLINE
| ID: mdl-23954627
We developed a quantitative method to measure the activity of cyclin-dependent kinases (Cdks) by western blotting, without radioisotopes. We prepared a recombinant protein substrate based upon the natural Cdk1 substrate, PP1Cα. By combining this substrate in a western blot method using fluorochrome based antibodies and phospho-imager analysis, we measured the Km of ATP binding to Cdk1 to be 3.5 µM. We then measured Cdk1 activity in cell extracts from interphase or mitotic cells, and demonstrated that previously identified Cdk inhibitors could be detected by this assay. Our data show that we have a safe, reliable assay to identify Cdk1 inhibitors and measure Cdk1 activity.
Palabras clave
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; CPT; Cdk1; Cdk2; DMSO; DTT; EGTA; HEPES; IPTG; Mitosis; PBS; Protein phosphatase 1Cα; Tissue culture; camptothecin; cyclin dependent kinase 1; cyclin dependent kinase 2; dimethyl sulfoxide; dithiothreitol; ethyleneglycol-bis (beta-aminoethylether)- N,N'-tetraacetic acid; isopropyl ß-d-1-thiogalactopyranoside; phosphate-buffered saline
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Proteínas Recombinantes de Fusión
/
Western Blotting
/
Proteína Quinasa CDC2
/
Proteína Fosfatasa 1
Tipo de estudio:
Prognostic_studies
Límite:
Humans
Idioma:
En
Revista:
FEBS Lett
Año:
2013
Tipo del documento:
Article
País de afiliación:
Canadá
Pais de publicación:
Reino Unido